These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 29227329
1. A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment. De Lemos-Bonotto M, Valle-Tovo C, Costabeber AM, Mattos AA, Azeredo-da-Silva ALF. Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):212-216. PubMed ID: 29227329 [Abstract] [Full Text] [Related]
3. Second-line Agents in Pediatric Patients With Autoimmune Hepatitis: A Systematic Review and Meta-analysis. Zizzo AN, Valentino PL, Shah PS, Kamath BM. J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):6-15. PubMed ID: 28644343 [Abstract] [Full Text] [Related]
4. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Chatur N, Ramji A, Bain VG, Ma MM, Marotta PJ, Ghent CN, Lilly LB, Heathcote EJ, Deschenes M, Lee SS, Steinbrecher UP, Yoshida EM. Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421 [Abstract] [Full Text] [Related]
5. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. Woynarowski M, Nemeth A, Baruch Y, Koletzko S, Melter M, Rodeck B, Strassburg CP, Pröls M, Woźniak M, Manns MP, European Autoimmune Hepatitis-Budesonide Study Group. J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723 [Abstract] [Full Text] [Related]
12. Expert clinical management of autoimmune hepatitis in the real world. Liberal R, de Boer YS, Andrade RJ, Bouma G, Dalekos GN, Floreani A, Gleeson D, Hirschfield GM, Invernizzi P, Lenzi M, Lohse AW, Macedo G, Milkiewicz P, Terziroli B, van Hoek B, Vierling JM, Heneghan MA, International Autoimmune Hepatitis Group (IAIHG). Aliment Pharmacol Ther; 2017 Mar; 45(5):723-732. PubMed ID: 28004405 [Abstract] [Full Text] [Related]
13. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. Richardson PD, James PD, Ryder SD. J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991 [Abstract] [Full Text] [Related]
14. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy. Than NN, Wiegard C, Weiler-Normann C, Füssel K, Mann J, Hodson J, Hirschfield GM, Lohse AW, Adams DH, Schramm C, Oo YH. Scand J Gastroenterol; 2016 Mar; 51(3):329-36. PubMed ID: 26458216 [Abstract] [Full Text] [Related]
15. Autoimmune hepatitis: Current and future therapeutic options. Doycheva I, Watt KD, Gulamhusein AF. Liver Int; 2019 Jun; 39(6):1002-1013. PubMed ID: 30716203 [Abstract] [Full Text] [Related]
20. The use of immunosuppression in autoimmune hepatitis: A current literature review. Cropley A, Weltman M. Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505 [Abstract] [Full Text] [Related] Page: [Next] [New Search]